Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia [Phase 2]
Phase 2 study recruiting to test adding venetoclax and/or blinatumomab to standard chemotherapy in infants with newly diagnosed KMT2A-rearra…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab [Phase 1, Phase 2]
Phase Ib/II clinical trial evaluating brexucabtagene autoleucel as consolidation therapy in relapsed/refractory and newly diagnosed B-cell a…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission [Phase 1]
This clinical trial update describes a Phase 1 CD19-directed CAR-T cell therapy trial for older adults with acute lymphoblastic leukemia in …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression [Phase 1, Phase 2]
AstraZeneca is evaluating AZD3632 as monotherapy or with other anticancer agents in adults with advanced hematologic malignancies associated…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity [Phase 2]
A Phase 2 clinical trial is evaluating resistance exercise plus an incretin-mimetic therapy to improve cardiometabolic health in survivors o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia [NA]
This clinical trial update describes a study evaluating transcutaneous auricular vagus nerve stimulation for insomnia in survivors of childh…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu... [NA]
This ClinicalTrials.gov entry describes a recruiting study evaluating next-generation sequencing for monitoring B-cell recovery to guide man…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: CAR-T Immunotherapy Targeting CD19- ALL [Phase 1, Phase 2]
This document updates a Phase 1/Phase 2 clinical trial of a CD19-targeted CAR-T cell therapy for B-cell acute lymphoblastic leukemia, sponso…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Childhood Cancer Survivors' Affective Response to Exercise
An ongoing clinical trial is evaluating how exercise affects affective responses in survivors of childhood cancer, including those with acut…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia [Phase 2]
Phase 2 study evaluating a condensed regimen (mini-Hyper-CVD with rituximab, inotuzumab ozogamicin, and blinatumomab) for relapsed pediatric…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of the TmBU Conditioning Regimen in high-risk or relapsed/refractory acute leuke…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Characterizing Sleep Among Long-term Survivors of Childhood Cancer
This clinical trial update describes a study examining sleep among long-term survivors of childhood cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors [NA]
A clinical trial sponsored by St. Jude Children's Research Hospital is recruiting to assess skeletal muscle mitochondrial oxidative phosphor…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer [NA]
Trial update indicates the NCT05550948 study on transcranial photobiomodulation to improve cognition in childhood cancer survivors is curren…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pilot Imaging Study of Leukemia [Phase 1]
Phase 1 pilot imaging study in leukemia is currently recruiting. Conditions listed include acute lymphoblastic leukemia, acute myeloid leuke…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3 [NA]
This clinical trial update indicates recruitment is ongoing for Study 3 investigating behavioral parenting skills to improve pediatric medic…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL [Phase 2]
A Phase 2 pediatric study to learn more about Inotuzumab Ozogamicin (InO) for first relapse acute lymphoblastic leukemia in children aged 1 …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
This is a clinical trial update describing a longitudinal study that assesses frailty in young adult survivors of childhood cancer; the stud…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia [Phase 2]
This clinical trial update describes a Phase 2 study of revumenib in combination with chemotherapy for relapsed or refractory leukemia, with…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Biology Studies of Hematologic Cancers
The document reports an NCI-sponsored biology-focused clinical trial update in hematologic cancers, with enrollment by invitation for condit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: CAR-T Cell Therapy Targeting to CD19 for R/R ALL [Phase 1, Phase 2]
An ongoing phase 1/2 clinical trial is evaluating a CD19-targeted CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia, c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAR T-cell Therapy in Patients With Renal Dysfunction [Phase 2]
A Phase 2 clinical trial evaluating CAR T-cell therapy in patients with renal dysfunction is currently recruiting for indications including …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial (TINI 2) evaluating total therapy for infants with acute lymphoblastic leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial is investigating intrathecal chemoprophylaxis to prevent neurotoxicity from blinatumomab in patients with acute lym…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
A clinical trial update describing leukapheresis collection for manufacturing CAR or adoptive cell therapies, with enrollment by invitation …